 Home > Medical News > Latest Medical News > Junshi PD-1 antibody combination is expected to expand indications for first-line treatment of patients with advanced lung cancer

Junshi PD-1 antibody combination is expected to expand indications for first-line treatment of patients with advanced lung cancer

 Last Update: 2022-01-11
 Source: Internet
 Author: User

Tags

transdermal drug delivery

cigs solar cell

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On December 13, 2021, Junshi Biosciences and Coherus Biosciences jointly announced the interim analysis results of a pivotal phase 3 clinical trial of toripalimab

In addition, the results presented at the World Conference on Lung Cancer (WCLC) in 2021 showed that the trial also reached the primary endpoint.

Teriprizumab is a recombinant humanized anti-PD-1 monoclonal antibody

A total of 465 patients with newly treated advanced NSCLC were enrolled in this phase 3 clinical trial

(The original text has been deleted)

Reference materials:

[1] Coherus and Junshi Biosciences Announce Positive Interim Overall Survival Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.